Vaccines
8 August 2016
Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer Reinforces Safety and Benefit of Novel Cancer Vaccine1 August 2016
The results of phase I clinical trial of the Araclon Biotech Alzheimer’s vaccine support its continuation27 July 2016
FluGen Initiates a Phase 1 Clinical Trial of the RedeeFlu™ Universal Influenza Vaccine in Healthy Subjects26 July 2016
Valneva Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate19 July 2016
VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus12 July 2016
VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports